Hospital Cost Savings for Sequential COPD Patients Receiving Domiciliary Nasal High Flow Therapy.

Richard J Milne Hans-Ulrich P HockeyJeffrey Garrett

Published in: International journal of chronic obstructive pulmonary disease (2022)

Domiciliary NHF therapy for patients with severe COPD has the potential to provide substantial hospital cost savings over the five-year lifetime of the NHF device.

Keyphrases

chronic obstructive pulmonary disease
lung function
healthcare
acute care
adverse drug
early onset
emergency department
stem cells
cystic fibrosis
electronic health record